A patient walked into clinic last month — 52, fit-looking, lifted weights three days a week for the last twenty years. His complaint was that his lifts had been sliding for about eighteen months despite no real change in training. His arms looked smaller in the mirror. He was tired in a way coffee was not solving, and his recovery between sessions had stretched from one day to three. His primary care doctor had run a basic panel, told him everything looked fine, and suggested he was "just getting older." He came to me because he did not buy that answer.
His total testosterone was 312 ng/dL. His free testosterone was below the assay floor. His SHBG was elevated, his fasting insulin was 14 mIU/L, and his vitamin D was 19 ng/mL. None of those numbers are catastrophic on their own. Together, they explained every symptom he had walked in with — and every one of them was treatable.
This is sarcopenia in the real world. It is not the picture most people have in their head, which is a frail eighty-year-old in a nursing home losing the ability to stand up. By the time it presents that way, decades of preventable loss have already happened. The clinical version of sarcopenia I see most often is the one that starts in the late thirties and accelerates through the forties and fifties — and it is hormonally and metabolically driven in ways conventional primary care frequently misses.
What sarcopenia actually is, mechanically
Skeletal muscle is not a static tissue. It is in constant turnover — protein synthesis on one side, protein breakdown on the other. In a healthy young adult with adequate testosterone, growth hormone, IGF-1, thyroid function, and protein intake, synthesis slightly exceeds breakdown, and muscle mass holds or grows. Somewhere around age 30, the balance starts to drift. By 40, the average sedentary adult is losing 0.5 to 1% of muscle mass per year. Past 60, that rate accelerates. Past 70, without intervention, it can run 2 to 3% per year.
The mechanism behind that drift is not just "aging." It is a measurable shift in the anabolic signaling environment. Testosterone declines roughly 1% per year after 30 in men, and the bioavailable fraction declines faster because SHBG climbs with age. Estrogen drops sharply through perimenopause in women, and estrogen plays a direct role in muscle protein synthesis and satellite cell function — which is why women lose muscle faster in the five years on either side of menopause than at any other point in life. Growth hormone secretion falls. IGF-1 follows. Insulin sensitivity worsens, which matters because insulin is one of the strongest anabolic signals the body produces, and an insulin-resistant muscle cell does not respond to dietary protein the way an insulin-sensitive one does — what we call anabolic resistance.
Add chronic low-grade inflammation, the kind driven by visceral fat and poor sleep, and protein breakdown accelerates while synthesis falls behind. The net result is what shows up in the mirror and on the lift log eighteen months later.
Why this is not "just aging" and why the conventional answer fails
Telling a 52-year-old that muscle loss is normal aging is technically true and clinically useless. The decline curve is not fixed. It is heavily modifiable, and the modifiable inputs are exactly the ones a standard primary care visit does not measure.
Standard panels measure total testosterone and stop there. In my experience, total testosterone in mid-life men is the least useful number on the page — what matters is free testosterone, SHBG, estradiol, and the ratio of those values to each other. A total testosterone of 450 ng/dL with an SHBG of 60 nmol/L produces a free testosterone deep in the deficient range, but the lab printout will say "normal" because the total number falls inside the reference range. That patient feels exactly as bad as a patient with a total of 280, and his muscle loss looks identical. The standard panel did not lie. It just did not ask the right question.
The same problem exists on the metabolic side. Fasting glucose stays normal for years while fasting insulin climbs into the teens — the pancreas compensates until it can't. By the time fasting glucose drifts above 100, the patient has been insulin resistant for a decade. That decade is when sarcopenia is being driven hardest, because insulin-resistant muscle cells do not absorb glucose and amino acids efficiently, and the patient cannot put on or hold lean mass no matter how hard they train.
What I look for when I evaluate someone for muscle loss
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
When I sit down with a patient presenting with the picture above, I am working through a specific list. The history is the first thing — when did the change start, what else changed at the same time, what does training look like, what is sleep doing, what medications and supplements are in play, what is alcohol intake, what is stress doing. I want to know if there has been a weight change in either direction, because both unexplained loss and stubborn central gain are signals.
Then the labs. The panel I order on a sarcopenia workup is broader than what most patients have ever had run. Sex hormones include total and free testosterone, SHBG, estradiol (yes, in men too — it matters for muscle and bone), DHEA-S, and progesterone in women. Thyroid is the full picture: TSH, free T3, free T4, reverse T3, and antibodies — because subclinical thyroid dysfunction is one of the most common drivers of fatigue and lean mass loss I see, and it gets missed when only TSH is checked. Metabolic includes fasting insulin and HOMA-IR, not just fasting glucose and HbA1c. Inflammatory and nutritional markers include hs-CRP, ferritin, vitamin D, B12, magnesium, and sometimes a homocysteine if the picture warrants it. If there is a story that makes me think about IGF-1 or cortisol patterns, I add those.
The comprehensive lab work panel is built around this question. I am not running every test in existence — that produces noise. I am running the panel that actually answers whether the patient's complaint has a treatable mechanism, and almost every time, it does.
How treatment proceeds when the workup confirms it
Once the data is in, the treatment plan is mechanism-first. If free testosterone is deficient and the picture supports it, men's hormone therapy is the most leveraged single intervention I have for restoring lean mass. Testosterone replacement, when properly dosed and monitored, reliably produces measurable lean mass gains within three to six months in deficient patients, and the strength curve typically follows. For women whose picture shows estrogen and testosterone decline, hormone optimization protocols address both — and the testosterone piece, which conventional women's care almost universally ignores, is often the difference between a patient who keeps her muscle through perimenopause and one who watches it disappear.
If insulin resistance is the bigger lever, the metabolic program addresses it directly. GLP-1 therapy combined with structured resistance training and protein-targeted nutrition restores insulin sensitivity at the muscle cell level, and once the cell is listening to insulin again, training adaptations return. Thyroid correction, when warranted, can move the needle on its own. Vitamin D repletion — and I mean repletion to the optimal range, not just above the deficiency cutoff — measurably improves muscle function in deficient patients.
The non-negotiable layer underneath all of this is mechanical loading. There is no hormone optimization protocol, no GLP-1 dose, no nutritional supplement that will build muscle in the absence of resistance training. The hormones unlock the capacity. The training is what writes the adaptation. Patients who hear that and commit to the training piece get the results the labs predict. Patients who expect the medication to do the work without the training get disappointed, and they should.
What the timeline actually looks like
Realistic expectations matter here because most patients underestimate how long sarcopenia took to develop and overestimate how fast it should reverse. Initial energy and recovery improvements show up in two to four weeks once a deficiency is corrected. Strength gains are usually noticeable by week six to eight. Measurable lean mass changes — the kind that show up on a DEXA scan — generally take three to six months. Full optimization, where the protocol is calibrated and the body composition trajectory is sustainable, is a nine-to-twelve month arc. I track response explicitly at the three-month and six-month reassessments because the dose that worked at month two may not be the dose that works at month nine, and the body composition data tells us whether we are actually building lean mass or just losing fat.
The next step if this is your picture
If what I have described sounds like what you have been dealing with, the next step is straightforward. Book a Columbus consultation or a Warner Robins consultation and bring whatever prior labs you have. If you do not have recent labs, we will order the full panel at the first visit. The lab review visit two weeks later is where the actual treatment conversation happens, with the data in front of both of us. The symptom assessment tool is a useful five minutes to spend before booking — it will help you arrive with the picture organized.
The patient I opened with started transdermal testosterone, addressed his vitamin D deficiency, and rebuilt his nutrition around adequate protein. Four months in, his free testosterone was in range, his fasting insulin had dropped to 8, his vitamin D was at 52, and his lifts were back where they had been three years earlier. None of that required heroic intervention. It required someone running the right labs and treating what they showed.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.